Detection of growth hormone doping by gene expression profiling of peripheral blood

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 12, 2009, Pages 4703-4709

  Mitchell, Christopher J ^a   Nelson, Anne E ^a   Cowley, Mark J ^a   Kaplan, Warren ^a   Stone, Glenn ^d   Sutton, Selina K ^a   Lau, Amie ^a   Lee, Carol M Y ^a   Ho, Ken K Y ^a,b,c  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOL 6 PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GROWTH HORMONE; HSPC 159 PROTEIN; ITGB 3 PROTEIN; MEMBRANE COFACTOR PROTEIN; OLFM 4 PROTEIN; PROTEIN; RNA; SOMATOMEDIN C; TBC1D25 PROTEIN; TRANSCRIPTOME; TUBB 1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; DOPING; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE TARGETING; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE; MALE; MICROARRAY ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEX DIFFERENCE; UPREGULATION; VALIDATION PROCESS;

EID: 73249118316     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1038     Document Type: Article

References (32)

1. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74
2. World Anti-Doping Agency 2009 World Anti-Doping Code 2009. http://www.wada-ama.org/rtecontent/document/code-v2009-En.pdf. Montreal: World Anti-Doping Agency
3. World Anti-Doping Agency 2009 The 2009 prohibited list. http://www.wada-ama.org/rtecontent/document/PL2009-EN-Final.pdf. Montreal: World Anti-Doping Agency
4. Nelson AE, Ho KK 2008 A robust test for growth hormone doping: present status and future prospects. Asian J Androl 10:416-425
5. Holt RI, Sönksen PH 2008 Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol 154:542-556
6. Nelson AE, Meinhardt U, Hansen JL, Walker IH, Stone G, Howe CJ, Leung KC, Seibel MJ, Baxter RC, Handelsman DJ, Kazlauskas R, Ho KK 2008 Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes. J Clin Endocrinol Metab 93:2213-2222
7. Bidlingmaier M, Suhr J, Ernst A, Wu Z, Keller A, Strasburger CJ, Bergmann A 2009 High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports. Clin Chem 55:445-453
8. Nguyen TV, Nelson AE, Howe CJ, Seibel MJ, Baxter RC, Handelsman DJ, Kazlauskas R, Ho KK 2008 Within-subject variability and analytic imprecision of insulinlike growth factor axis and collagen markers: implications for clinical diagnosis and doping tests. Clin Chem 54:1268-1276
9. Clark R 1997 The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocr Rev 18:157-179
10. Redelman D, Welniak LA, Taub D, Murphy WJ 2008 Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network. Cell Immunol 252:111-121
11. Shimizu K, Adachi K, TeramotoA 2005 Growth hormone enhances natural killer cell activity against glioma. J Nippon Med Sch 72:335-340
12. Chen HT, Schuler LA, Schultz RD 1998 Growth hormone receptor and regulation of gene expression in fetal lymphoid cells. Mol Cell Endocrinol 137:21-29
13. Baxter RC, Brown AS, Turtle JR 1982 Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure. Clin Chem 28:488-495
14. Smyth GK 2004 Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3
15. Ritchie ME, Diyagama D, Neilson J, van Laar R, Dobrovic A, Holloway A, SmythGK 2006 Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics 7:261
16. Ihaka R, Gentleman R 1996 R: a language for data analysis and graphics. J Comput Graph Stat 5:299-314
17. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J 2004 Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
18. Dudoit S, Fridlyand J, Speed TP 2000 Comparison of discrimination methods for the classification of tumors using gene expression data. Tech Rep 576. Berkeley, CA: University of California, Berkeley
19. Storey JD, Tibshirani R 2003 Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100:9440-9445
20. -ΔΔCT method. Methods 25:402-408
21. Eady JJ, Wortley GM, Wormstone YM, Hughes JC, Astley SB, Foxall RJ, Doleman JF, Elliott RM 2005 Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics 22:402-411
22. Whatmore AJ, Patel L, Clayton PE 2009Apilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children withGHdeficiency and Turner syndrome in response to GH treatment. Clin Endocrinol (Oxf) 70:429-434
23. Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK 2005 Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 289:E266-E271
24. Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH, Leong GM, Ross RJ, Ho KK 2003 Estrogen inhibitsGHsignaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA 100:1016-1021
25. Bouman A, Heineman MJ, Faas MM 2005 Sex hormones and the immune response in humans. Hum Reprod Update 11:411-423
26. Svensson J, Tivesten A, Sjögren K, Isaksson O, Bergström G, Mohan S, Mölne J, Isgaard J, Ohlsson C 2007 Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression. J Endocrinol 193:359-366
27. Lariviere L, Geiger S, Hoeppner S, Rother S, Strasser K, Cramer P 2006 Structure and TBP binding of the Mediator head subcomplex Med8-Med18-Med20. Nat Struct Mol Biol 13:895-901
28. Sjögren K, Leung KC, Kaplan W, Gardiner-Garden M, Gibney J, Ho KK 2007 Growth hormone regulation of metabolic gene expression in muscle: a microarray study in hypopituitary men. Am J Physiol Endocrinol Metab 293:E364-E371
29. Vitale L, Casadei R, Canaider S, Lenzi L, Strippoli P, D'Addabbo P, Giannone S, Carinci P, Zannotti M 2002 Cysteine and tyrosine-rich 1 (CYYR1), a novel unpredicted gene on human chromosome 21 (21q21.2), encodes a cysteine and tyrosine-rich protein and defines a new family of highly conserved vertebrate-specific genes. Gene 290:141-151
30. Xian CJ 2007 Roles of epidermal growth factor family in the regulation of postnatal somatic growth. Endocr Rev 28:284-296
31. Qi Y, Operario DJ, Oberholzer CM, Kobie JJ, Mosmann TR 2009 The expression and regulation of amphiregulin on human basophils and CD4 T cells. J Immunol 182:36.16 (Abstract)
32. Chang CI, Liao JC, Kuo L 2001 Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res 61:1100-1106